Dulaglutide vs Survodutide

Dulaglutide (brand name Trulicity) is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes and reduce cardiovascular risk. Survodutide, still in development, is a dual-acting drug that targets both GLP-1 and glucagon receptors, but it has not yet been approved for any use.

AI summary of the sources below.